Institute of Virology, Helmholtz Zentrum München, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany.
J Clin Virol. 2012 Oct;55(2):114-20. doi: 10.1016/j.jcv.2012.06.017. Epub 2012 Jul 13.
Several correlates of HIV control have been described; however their predictive values remain unclear, since most studies have been performed in cross-sectional settings.
We evaluated the cause and consequence relationship between quality of HIV-specific T-cell response and viral load dynamic in a temporal perspective.
HIV-1-specific T-cell responses were monitored over 7 years in a patient that following treatment interruption maintained a stable/low viral set point for 3.1 years before control of viral replication was lost and antiretroviral therapy restarted.
We observed that high frequencies of HIV-1-specific CD4 and CD8 T cells were unable to prevent loss of viral control. Gradual loss of functionality was observed in these responses, characterized by early loss of IL-2, viral load-dependent decrease of IFN-γ and CD154 expression as well as increase of MIP-1β production. Terminally differentiated HIV-1-specific CD8 T cells expressing CD45RA were lost independently of viral load and preceded the loss-of-control phase of HIV infection.
By describing qualitative changes in HIV-1-specific T-cell responses that coincide with loss of viral control, we identified specific correlates of disease progression and putative markers of viral control. Our findings suggest including the markers IL-2, IFN-γ, MIP-1β, CD154 and CD45RA into monitoring of HIV-specific T-cell-responses to prospectively determine correlates of protection from disease-progression.
已经描述了几种与 HIV 控制相关的因素;然而,由于大多数研究都是在横断面研究中进行的,因此它们的预测价值尚不清楚。
我们从时间角度评估了 HIV 特异性 T 细胞反应的质量与病毒载量动态之间的因果关系。
在一名患者中,HIV-1 特异性 T 细胞反应在 7 年内进行了监测,该患者在停止治疗后 3.1 年内保持稳定/低病毒基准,然后失去病毒复制控制并重新开始抗逆转录病毒治疗。
我们观察到高频率的 HIV-1 特异性 CD4 和 CD8 T 细胞无法预防病毒控制的丧失。这些反应中观察到功能逐渐丧失,其特征是早期丧失 IL-2,病毒载量依赖性 IFN-γ和 CD154 表达下降以及 MIP-1β产生增加。表达 CD45RA 的终末分化 HIV-1 特异性 CD8 T 细胞独立于病毒载量丢失,并先于 HIV 感染的控制丢失阶段。
通过描述与病毒控制丧失一致的 HIV-1 特异性 T 细胞反应的定性变化,我们确定了疾病进展的特定相关因素和潜在的病毒控制标志物。我们的研究结果表明,将 IL-2、IFN-γ、MIP-1β、CD154 和 CD45RA 等标志物纳入 HIV 特异性 T 细胞反应监测中,以前瞻性地确定免受疾病进展保护的相关因素。